基于CT的肝脏瘤周影像组学特征可预测肝转移来源为胃肠道或非胃肠道
本研究纳入347例肝转移患者(胃肠道来源180例、非胃肠道来源167例),利用腹部对比增强CT动脉期、门静脉期和延迟期提取肿瘤及瘤周区域的影像组学特征,构建逻辑回归模型预测转移来源。验证集中,动脉期与静脉期瘤周联合模型表现最佳,AUC为0.926,测试集AUC为0.884;最佳单期模型为静脉期瘤周模型(11个特征),验证集AUC为0.817。
要点
- 静脉期瘤周影像组学单期模型在验证集AUC为0.817,敏感度0.740、特异度0.761。
- 动脉期与静脉期瘤周联合模型(15个特征)验证集AUC为0.926、测试集AUC为0.884。
- 最佳单期肿瘤区域模型为动脉期,验证集AUC仅0.677。
核心结论
- 基于对比增强CT提取的肝脏瘤周影像组学特征能够区分肝转移来源于胃肠道还是非胃肠道原发肿瘤。
- 动脉期与静脉期瘤周影像组学特征在区分肝转移来源方面具有前景。
研究设计与样本
- 回顾性研究?原文未明确写回顾性,只写将347例肝转移患者(胃肠道来源180例、非胃肠道来源167例)按7:3分为训练集221例和验证集96例,并另设独立测试集30例。
- 所有患者均行腹部对比增强CT,包括动脉期、门静脉期和延迟期。
- 从对比增强CT的肿瘤区域和瘤周区域感兴趣体积中提取影像组学特征,采用逻辑回归模型并通过受试者工作特征曲线分析评估诊断效能。
诊断标准与关键数值
- 最佳单期模型为静脉期瘤周感兴趣体积模型(11个特征),验证集AUC为0.817、敏感度为0.740、特异度为0.761。
- 最佳单期肿瘤区域模型为动脉期,验证集AUC为0.677。
- 联合模型中,动脉期与静脉期瘤周感兴趣体积模型(15个特征)预测性能最佳,验证集AUC为0.926、测试集AUC为0.884。
临床应用与阅片要点
- 原文结论认为肝脏瘤周影像组学特征能够识别肝转移来源为胃肠道或非胃肠道,动脉期与静脉期瘤周特征在区分来源方面具有前景。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate the feasibility of radiomics models for predicting the source of hepatic metastases from gastrointestinal (GI) vs non-gastrointestinal (non-GI) primary tumours on contrast-enhanced CT (CECT).
METHODS: Three hundred and forty-seven patients with liver metastases (180 from GI and 167 from non-GI) and abdominal CECT including arterial, portal venous, and delayed phases were divided into training (221) and validation (96) sets at a ratio of 7:3 and an independent testing set (30). Radiomics features were extracted from volumes of interest (VOIs) including tumoural (Vtc) and peritumoural (Vpt) regions on CECT. Optimal radiomics features were used in logistic regression models using receiver operating curve (ROC) analysis to evaluate the diagnostic efficiency.
RESULTS: The best single-phase model was a venous phase peritumoural VOI with 11 features. Area under the curve (AUC), sensitivity, and specificity were 0.817, 0.740, and 0.761, respectively in the validation set. While the best arterial phase tumoural VOI gave an AUC of 0.677 in the validation set. For the combined models, peritumoural VOI in arterial and venous phases (15 features) achieved the best prediction performance with an AUC of 0.926 in the validation set and 0.884 in the testing set.
CONCLUSION: Liver peritumoural radiomics features extracted from CECT were able to identify the source of hepatic metastases as GI vs non-GI.
ADVANCES IN KNOWLEDGE: Peritumoural radiomics features showed a correlation with source of liver metastases. The radiomics features from liver peritumoural arterial and venous phases CT were promising in differentiating the source of hepatic metastases from GI vs non-GI primary tumours.
引用
- Hou C, Wang F, Prince M, et al. CT-based liver peritumoural radiomics features predict hepatic metastases sources as gastrointestinal or non-gastrointestinal. Br J Radiol. 2025. PMID: 39719063. doi:10.1093/bjr/tqae248
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。